The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
An article from
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
Published July 28, 2026
A GSK logo is seen on the side of an office building in Poznan, Poland.
Getty Images
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
GSK lays out plans to cut costs, pursue more late-stage drug trials
Sweeping job cuts at GSK to fund £400m Cambridge campus
GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain
Why Is GSK Stock Gaining Tuesday? - GSK (NYSE:GSK)
GSK announces plans to close main research hub in Stevenage
Pharma giant to relocate research hub to Cambridge in £400m move
Roche Cuts Generic Impact Estimate, Pointing to More Growth
GLP-1s and the High Cost of Providing Health Care
GSK to shut Stevenage R&D hub under plans to open new site in Cambridge
